Across different freshly resected IDHwt GBM samples, we found that targeting both MCL-1 and BCL-xL led to an extensive induction of apoptosis and sustained reduction in tumour cell viability ex vivo, without compromising tissue and vessel integrity. The gene discussed is MCL1; the disease is neoplasm.